Market Cap$48.77B
P/E37.43x
PEG Ratio1.44
Div yield0.75%
Beta1.25
A Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)36.91%
Price vs S&P 500 (4W)10.87%
PEG Ratio1.44
VGM Score56.54
P/E Ratio (Annual)37.43x
Indicated Dividend Yield (Annual)0.75%
A Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $1.49 | $1.62 | +9.01%(+$0.13) | |
| Q1 2026 | $1.41 | $1.49 | +5.80%(+$0.08) | |
| Q4 2025 | $1.37 | $1.36 | -0.60%(-$0.01) | |
| Q3 2025 | $1.58 | $1.59 | +0.37%(+$0.01) | |
| Q2 2025 | $1.37 | $1.37 | +0.17%(+$0.00) |
A Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.04
4.07
4.03
4.03
Industry Peers — Lab Analytical Instruments(25)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
AAgilent Technologies Inc. | D | C | A | 6.6x | 5.4% | 53.9% | 22.2% | $172.97 |
| WATWaters Corp | F | C | A | 9.4x | 6.0% | 50.9% | 7.1% | $436.95 |
| ILMNIllumina Inc | D | D | A | 8.8x | 6.0% | 66.4% | 19.5% | $262.54 |
| MTDMettler-Toledo International | D | C | A | 7.9x | 5.5% | 60.3% | 26.6% | $1622.29 |
| RVTYRevvity, Inc. | D | D | A | 5.8x | -5.5% | 55.0% | 12.3% | $152.64 |
| AVTRAvantor, Inc. | C | F | A | 1.7x | 0.5% | 31.8% | -4.7% | $16.42 |
| BIO.BBio-Rad Laboratories, Inc. Class B | C | D | B | 3.7x | 0.3% | 51.9% | 1.8% | $364.15 |
| BIOBio-Rad Laboratories, Inc.Class A | C | D | B | 3.7x | 0.3% | 51.9% | 1.8% | $353.70 |
| TXG10x Genomics, Inc. Class A Common Stock | F | D | A | 14.8x | 16.6% | 69.6% | -14.3% | $69.86 |
| BRKRBruker Corporation | D | D | B | 2.4x | 11.6% | 47.7% | -1.5% | $54.80 |
| ALMRAlamar Biosciences, Inc. Common Stock | — | A | B | — | — | — | — | $25.28 |
About Agilent Technologies Inc.
Agilent Technologies, spun out of Hewlett-Packard in 1999, is a leading measurement and diagnostics company serving life sciences, diagnostics, and applied end markets through consumables, services, and instruments. Over 50% of revenue comes from biopharmaceutical, chemical, and advanced materials customers—sticky, mission-critical applications—while also serving clinical, environmental, forensics, food, and academic markets. The company maintains geographic diversification with significant operations in the US and China.